Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Third-party quality oversight: designing and implementing a quality oversight programme

This article was originally published in SRA

  • News
  • John Wilson

Executive Summary

John Wilson explains how pharmaceutical and medical device sponsors can gain more confidence in their clinical trial data through quality oversight of clinical trials vendors.

You may also be interested in...



2012 Scrip 100: The all-seeing eye

Several high-profile cases of failure to properly monitor, data mismanagement or in extreme cases, falsification, have made the issue of vendor oversight today's news, and today's imperative. John Wilson of the CRO Beaufort explains how to create a vendor oversight programme.

Third-party quality oversight: designing and implementing a quality oversight programme

John Wilson explains how pharmaceutical and medical device sponsors can gain more confidence in their clinical trial data through quality oversight of clinical trials vendors.

Third-party quality oversight: designing and implementing a quality oversight programme

John Wilson explains how pharmaceutical and medical device sponsors can gain more confidence in their clinical trial data through quality oversight of clinical trials vendors.

Table

View full table

Tags:
Latest Headlines

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation

Second EU MDR Notified Body Designated In France

Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217

See All
UsernamePublicRestriction

Register

MT039466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By